Insider · CIK 0001884248
Yizhe Wang
Files at ZLAB (Zai Lab Ltd). First filing -, latest -.
In brief
Yizhe Wang files SEC Form 4 as officer at ZLAB (Zai Lab Ltd). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Yizhe Wang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 8, 2024 | LIANY LianBio | 820,000 0.77% of outstanding | $3.4M | Jan 8, 2024 | $939k |
| Dec 29, 2023 | LIANY LianBio | 250,000 0.23% of outstanding | $1.1M | Dec 29, 2023 | none |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ZLAB Zai Lab Ltd | AGrant or award Stock Option (Right to Buy)derivative | +136,819 | $0.00 | $0 | 136,819 | Jun 8, 2026 |
| May 11, 2026 | ZLAB Zai Lab Ltd | AGrant or award Restricted Share Unitsderivative | +59,288 | $0.00 | $0 | 59,288 | Jun 8, 2026 |
Questions about Yizhe Wang
Answered from the filings on this page, as of the latest one.
Is Yizhe Wang buying or selling?
Yizhe Wang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Yizhe Wang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yizhe Wang has 0.
Where does Yizhe Wang file Form 4?
Yizhe Wang has filed Form 4 at ZLAB (Zai Lab Ltd) as Operating Partner. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.